Mirae Asset Global Etfs Holdings Ltd. Abbott Laboratories Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $41.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Abbott Laboratories stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 157,484 shares of ABT stock, worth $18.5 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
157,484
Previous 165,387
4.78%
Holding current value
$18.5 Million
Previous $17.2 Million
4.47%
% of portfolio
0.04%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding ABT
# of Institutions
3,186Shares Held
1.3BCall Options Held
8.74MPut Options Held
8.08M-
Vanguard Group Inc Valley Forge, PA168MShares$19.8 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY131MShares$15.4 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$9.03 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$7.74 Billion1.49% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$6.28 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $206B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...